Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

Share Price is delayed by 15 minutes
Get Live Data
28.75    -0.50 (-1.71%)
Bid:
28.50
Ask:
29.00
Spread: 0.50 (1.754%)
Market Cap: £121.51m
MERC Live PriceLast checked at - London Stock Exchange

Intraday Mercia Asset Share Chart

Trading Update

1 May 2008 07:01

Merchant Securities PLC01 May 2008 1 May 2008 Merchant Securities plc ("Merchant Securities" or the "Company") Trading update The Board of Merchant Securities, the financial services company specialising inprivate client and institutional stockbroking, corporate finance services andprivate equity, announces a trading update for the year ended 31March 2008. As stated at the time of the Company's interim announcement in December 2007,the Company continues to make progress in developing its core activities and instrengthening the infrastructure of its business. In this regard, the Companyhas achieved the following strategic developments in the second half of itsfinancial year: β€’ Merchant Securities Group Limited, ("MSGL") its stockbroking subsidiary, became a member of the London Stock Exchange in February 2008; β€’ A new, upgraded private client investment management system and a transfer of the settlement and clearing functions to Pershing in February 2008; β€’ Its management team has been strengthened by the appointment of a new Chief Financial Officer and a new Compliance Officer; β€’ In October 2007, it completed the acquisition of John East & Partners, a corporate finance adviser, nominated adviser and corporate broker, which made a positive contribution to the group, post acquisition, in the year ended 31 March 2008; β€’ It has recruited a senior institutional research and sales team which is due to join MSGL within the next two months. As a result of these developments, a number of costs have been incurred. Inaddition, market conditions have deteriorated since the announcement of theCompany's interim results and a number of the larger private equity transactionsin progress at that time have not been completed as originally anticipated.Consequently, the Company expects that it will have incurred a loss aftertaxation in the region of Β£600,000, after taking account of non-recurring itemsof approximately Β£400,000, in the financial year ended 31 March 2008. The board continues to pursue its strategy of building a diversified financialservices group and some non-recurring reorganisation costs are an inevitableconsequence. The board remains confident that the successful implementation ofits strategy will see significant benefits accruing to the Company in the mediumterm. The Company expects to announce it results for the year ended 31 March 2008 inthe second half of July 2008. ENDS For further information please contact: Anthony Fabrizi Chief Executive 020 7375 9060 Merchant Securities Roland Cross Director 020 7726 6111 Broadgate Richard Day Director 020 7398 1600 Arden Partners plc This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
5th Oct 20177:00 amRNSFurther significant fund realisation achieved
3rd Oct 20177:00 amRNSWebsite launch
20th Sep 20177:00 amRNS£3.1million syndicated investment
18th Sep 201711:05 amRNSResult of AGM
18th Sep 20177:00 amRNSAGM statement
21st Aug 20177:00 amRNS£2.0m investment into Oxford Genetics
2nd Aug 20177:00 amRNSBoard Change
25th Jul 20177:00 amRNSGrant Options & PDMR Dealings
21st Jul 20177:00 amRNSPublication of Annual Report
13th Jul 20177:00 amRNSMercia invests additional £2.0million into nDreams
3rd Jul 20177:00 amRNSPreliminary results
21st Jun 20177:00 amRNSInvestment into Impression Tech & Sector Update
6th Jun 20177:00 amRNSFurther investment into Oxford Genetics
3rd May 20177:00 amRNSNotice of Preliminary Results
22nd Feb 20177:00 amRNSTwo major contracts for Northern Powerhouse Funds
17th Feb 201712:00 pmRNSNotification of Major Interest in Shares
16th Feb 201710:43 amRNSResult of General Meeting & Completion of Placing
31st Jan 20172:40 pmRNSPlacing of new Ordinary Shares to raise c.£40.0m
26th Jan 20177:00 amRNSNotice of Mercia Annual Gala Dinner
18th Jan 20177:00 amRNSNew Direct Investment in Faradion Limited
16th Dec 20167:00 amRNSSale of Allinea Software Limited to ARM
16th Nov 20167:00 amRNS£1m invested in nDreams as part of £2m syndication
10th Nov 20167:00 amRNSHalf Year Results
28th Oct 20167:00 amRNSNotice of Results
27th Oct 20167:00 amRNSInvestment in Oxford Genetics Limited
19th Oct 20167:00 amRNSWarwick Audio Technologies strengthens Board
11th Oct 20167:00 amRNSDigital & Digital Entertainment Portfolio Update
5th Oct 20167:00 amRNSCapital Markets Event
27th Sep 20167:00 amRNSInvestment into innovative healthcare - Medherant
19th Sep 201610:36 amRNSResult of AGM
26th Aug 20167:00 amRNSDirector/PDMR Shareholdings
29th Jul 20167:00 amRNSPublication of Annual Report
28th Jul 20167:00 amRNSGrant Options & PDMR Dealings
26th Jul 20168:30 amRNSRe. Admission to AIM of Concepta PLC
21st Jul 20167:00 amRNSnDreams launches The Assembly for Oculus RIFT
7th Jul 20167:00 amRNSAcquisition, Placing & Open Offer, Change of Name
7th Jul 20167:00 amRNSFundraising & AIM Admission of Direct Investment
30th Jun 20167:00 amRNSPreliminary Results
20th Jun 20167:00 amRNSFour New University Partnerships
1st Jun 20167:00 amRNSNotice of Preliminary Results
26th May 20167:00 amRNSBoard Changes
20th May 20167:00 amRNSMercia's nDreams signs Google VR app deal
9th May 20167:00 amRNSFirst Direct Investment via Enterprise Ventures
17th Mar 20163:30 pmRNSNotification of Major Interest in Shares
17th Mar 20167:00 amRNSNew Direct Investment
10th Mar 20167:02 amRNSAcquisition of Enterprise Ventures
21st Jan 20167:00 amRNSNotice of Mercia Fund Management AGM
15th Dec 20157:00 amRNSThree additional university partnerships
3rd Dec 20157:00 amRNSHalf Yearly Report
10th Nov 20157:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.